KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma
KDF1 has been identified as a key regulator of epidermal proliferation and differentiation, but it is unknown whether KDF1 is involved in the pathogenesis of malignancy. No study has reported the expression and function of KDF1 in renal cancer. To explore the pathologic significance of KDF1 in clear...
Main Authors: | Jing-min Zheng, Mei-fu Gan, Hong-yuan Yu, Lu-xia Ye, Qing-xin Yu, Yu-hui Xia, Han-xi Zhou, Jia-qian Bao, Yi-qing Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.686678/full |
Similar Items
-
WAR TERMINATION IN SOMALIA AND KENYA DEFENSE FORCES’ (KDF) ROLE
by: E.O.S. ODHIAMBO, et al.
Published: (2013-01-01) -
Dysregulation of Ketone Body Metabolism Is Associated With Poor Prognosis for Clear Cell Renal Cell Carcinoma Patients
by: Wanmeng Cui, et al.
Published: (2019-12-01) -
Hypermethylation of the 16q23.1 Tumor Suppressor Gene ADAMTS18 in Clear Cell Renal Cell Carcinoma
by: Ben Xu, et al.
Published: (2015-01-01) -
Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma
by: Yan Liu, et al.
Published: (2018-01-01) -
IGFLR1 as a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates
by: Wenjing Song, et al.
Published: (2020-11-01)